These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 36141691)

  • 21. Health technology assessment and priority setting for universal health coverage: a qualitative study of stakeholders' capacity, needs, policy areas of demand and perspectives in Nigeria.
    Uzochukwu BSC; Okeke C; O'Brien N; Ruiz F; Sombie I; Hollingworth S
    Global Health; 2020 Jul; 16(1):58. PubMed ID: 32641066
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bridging health technology assessment (HTA) and efficient health care decision making with multicriteria decision analysis (MCDA): applying the EVIDEM framework to medicines appraisal.
    Goetghebeur MM; Wagner M; Khoury H; Levitt RJ; Erickson LJ; Rindress D
    Med Decis Making; 2012; 32(2):376-88. PubMed ID: 21987539
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Introducing an Ethics Framework for health priority-setting in South Africa on the path to universal health coverage.
    Blaauw D; Chambers C; Chirwa T; Duba N; Gwyther L; Hofman K; London L; Masilela T; McKerrow N; Modupe O; Moeng L; Mubaiwa V; Nematswerani N; Ramkissoon Y; Saloojee Y; Tshabalala S; Valabhjee K; Versteeg-Mojanaga M; Barsdorf N; Conco D; DiStefano M; Li R; Chalkidou K; Faden R; Goldstein S; Hofman K; Krubiner CB; Merritt MW; Mosam A; Potgieter S; Tugendhaft A
    S Afr Med J; 2022 Mar; 112(3):240-244. PubMed ID: 35380528
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evidence-Informed Deliberative Processes for Universal Health Coverage: Broadening the Scope Comment on "Priority Setting for Universal Health Coverage: We Need Evidence-Informed Deliberative Processes, Not Just More Evidence on Cost-Effectiveness".
    Gopinathan U; Ottersen T
    Int J Health Policy Manag; 2017 Aug; 6(8):473-475. PubMed ID: 28812847
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Addressing Health System Values in Health Technology Assessment: The Use of Evidence-Informed Deliberative Processes.
    Oortwijn W; Klein P
    Int J Technol Assess Health Care; 2019; 35(2):82-84. PubMed ID: 30957730
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Defining the Benefit Package of Thailand Universal Coverage Scheme: From Pragmatism to Sophistication.
    Tangcharoensathien V; Patcharanarumol W; Suwanwela W; Supangul S; Panichkriangkrai W; Kosiyaporn H; Witthayapipopsakul W
    Int J Health Policy Manag; 2020 Apr; 9(4):133-137. PubMed ID: 32331492
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Role of HTA for Essential Health Benefit Package Design in Low or Middle-Income Countries.
    Norheim OF; Watkins DA
    Health Syst Reform; 2023 Dec; 9(3):2273051. PubMed ID: 37948391
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mentoring a health technology assessment initiative in Kazakhstan.
    Muratov S; Hailey D; Foerster V; Brady B; Juzwishin D; la Fleur P; McGowan J
    Int J Technol Assess Health Care; 2014 Apr; 30(2):147-52. PubMed ID: 24774034
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multicriteria decision analysis for including health interventions in the universal health coverage benefit package in Thailand.
    Youngkong S; Baltussen R; Tantivess S; Mohara A; Teerawattananon Y
    Value Health; 2012; 15(6):961-70. PubMed ID: 22999148
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multicriteria Decision Analysis to Support Health Technology Assessment Agencies: Benefits, Limitations, and the Way Forward.
    Baltussen R; Marsh K; Thokala P; Diaby V; Castro H; Cleemput I; Garau M; Iskrov G; Olyaeemanesh A; Mirelman A; Mobinizadeh M; Morton A; Tringali M; van Til J; Valentim J; Wagner M; Youngkong S; Zah V; Toll A; Jansen M; Bijlmakers L; Oortwijn W; Broekhuizen H
    Value Health; 2019 Nov; 22(11):1283-1288. PubMed ID: 31708065
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Value Assessment Frameworks for HTA Agencies: The Organization of Evidence-Informed Deliberative Processes.
    Baltussen R; Jansen MPM; Bijlmakers L; Grutters J; Kluytmans A; Reuzel RP; Tummers M; der Wilt GJV
    Value Health; 2017 Feb; 20(2):256-260. PubMed ID: 28237205
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Don't Discount Societal Value in Cost-Effectiveness Comment on "Priority Setting for Universal Health Coverage: We Need Evidence-Informed Deliberative Processes, Not Just More Evidence on Cost-Effectiveness".
    Hall W
    Int J Health Policy Manag; 2017 Sep; 6(9):543-545. PubMed ID: 28949468
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Developing and piloting a context-specified ethics framework for health technology assessment: the South African Values and Ethics for Universal Health Coverage approach.
    Krubiner CB; Barsdorf NW; Goldstein SJ; Mosam A; Potgieter S; DiStefano MJ; Tugendhaft A; Merritt MW; Li R; Chalkidou K; Faden RR; Hofman KJ
    Int J Technol Assess Health Care; 2022 Mar; 38(1):e26. PubMed ID: 35256036
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Field testing of a multicriteria decision analysis (MCDA) framework for coverage of a screening test for cervical cancer in South Africa.
    Miot J; Wagner M; Khoury H; Rindress D; Goetghebeur MM
    Cost Eff Resour Alloc; 2012 Feb; 10(1):2. PubMed ID: 22376143
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Application of HTA research on policy decision-making.
    Youngkong S
    J Med Assoc Thai; 2014 May; 97 Suppl 5():S119-26. PubMed ID: 24964709
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TESTING MULTI-CRITERIA DECISION ANALYSIS FOR MORE TRANSPARENT RESOURCE-ALLOCATION DECISION MAKING IN COLOMBIA.
    Castro Jaramillo HE; Goetghebeur M; Moreno-Mattar O
    Int J Technol Assess Health Care; 2016 Jan; 32(4):307-314. PubMed ID: 27691990
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Health Technology Assessment: Global Advocacy and Local Realities Comment on "Priority Setting for Universal Health Coverage: We Need Evidence-Informed Deliberative Processes, Not Just More Evidence on Cost-Effectiveness".
    Chalkidou K; Li R; Culyer AJ; Glassman A; Hofman KJ; Teerawattananon Y
    Int J Health Policy Manag; 2017 Apr; 6(4):233-236. PubMed ID: 28812807
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Application of evidence-informed deliberative processes in health technology assessment in low- and middle-income countries.
    Oortwijn W; van Oosterhout S; Kapiriri L
    Int J Technol Assess Health Care; 2020 Jul; ():1-5. PubMed ID: 32715993
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reinforcing Science and Policy, With Suggestions for Future Research Comment on "Evidence-Informed Deliberative Processes for Health Benefit Package Design - Part II: A Practical Guide".
    Culyer AJ
    Int J Health Policy Manag; 2023; 12():7398. PubMed ID: 35942975
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.